BURT DOBSON: Open Payments
NPI 1336321926 · WHITEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 58 payments from 12 companies in 2025. Trend: 2023 $732 · 2024 $762 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $214 |
| Teva Pharmaceuticals USA, Inc. | 11 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $124 |
| E.R. Squibb & Sons, L.L.C. | 5 | $118 |
| Neurocrine BioSciences, Inc. | 6 | $117 |
| Vanda Pharmaceuticals Inc. | 5 | $106 |
| Janssen Pharmaceuticals, Inc | 6 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| ABBVIE INC. | 2 | $30 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
Products named: ARISTADA, CAPLYTA, COBENFY, INGREZZA, HETLIOZ, INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
